Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus bupivacaine adductor canal block after total knee arthroplasty in elderly patients
ChiCTR2400093147Phase 4Recruiting
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Nov 2024
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine and bupivacaine in postoperative pain and knee osteoarthritis (OA) (2 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoint: Area under the resting pain intensity-time curve from 0 to 72 hours. Started Nov 2024; status: recruiting.
02
Drugs
liposomal bupivacainebupivacaine
03
Conditions
postoperative painknee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400093147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093147.